Shivashish Dobhal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shivashish Dobhal has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Akshat Uniyal
Alpine Institute of Management and Technology, Dehradun, India
1 shared publication - Ankur Kumar
Department of Microbiology, All India Institute of Medical Sciences, Rishikesh 249203, India
1 shared publication - Ashish Kothari
Department of Ophthalmology and Visual Science, University of Michigan, MI 48105, USA
1 shared publication - Balram Ji Omar
Department of Microbiology, AIIMS Rishikesh, Uttarakhand 249203
1 shared publication - Hardeep Singh Manhas
Centre of Excellence for Use of Drones in Medicine, Department of Telemedicine, AIIMS Rishikesh, India
1 shared publication - Himanshu Kohli
Amity Institute of Biotechnology, Amity University, Noida, India
1 shared publication
Latest Publications
- 25 November 2025
- Published by Springer Nature in Indian Journal of Microbiology
- Vol. 66 (3) , 553-573
Crossroad Between Gut Microbiome and Ischemic Stroke: Underlying Pathways and Therapeutic Possibilities
Stroke is a cerebrovascular condition that has emerged as the major cause of death globally, among other non-communicable diseases, due to its pathophysiological complexity and varied etiologies. Ischemic stroke (IS) represents the most prevalent subtype accounting for more than 70% of all stroke cases worldwide. The gut microbiome is considered the most abundant pool of microorganisms, which release metabolic products that facilitate gut-brain signaling. Despite advancements, the precise processes by which gut microbes influence stroke pathogenesis are not entirely understood. This review explores the immunomodulatory impact of gut-derived metabolites in IS, with a focus on short-chain fatty acids (SCFAs) and other bioactive substances. A comprehensive literature search was undertaken using MeSH terms such as gut microbiome, ischemic stroke, cerebral ischemia, brain infarction, intestinal flora, and gut-brain axis. We address how metabolites such as short-chain fatty acids produced by gut bacteria influence the host's immune system, which in turn affects the activity of neural networks linked to atherosclerosis, a major underlying mechanism of IS. Furthermore, this review also looks at new research opportunities and highlights evidence from studies conducted on humans and animals.
- 25 November 2025
- Published by Springer Nature in Indian Journal of Microbiology
- Vol. 66 (3) , 553-573
Crossroad Between Gut Microbiome and Ischemic Stroke: Underlying Pathways and Therapeutic Possibilities
Stroke is a cerebrovascular condition that has emerged as the major cause of death globally, among other non-communicable diseases, due to its pathophysiological complexity and varied etiologies. Ischemic stroke (IS) represents the most prevalent subtype accounting for more than 70% of all stroke cases worldwide. The gut microbiome is considered the most abundant pool of microorganisms, which release metabolic products that facilitate gut-brain signaling. Despite advancements, the precise processes by which gut microbes influence stroke pathogenesis are not entirely understood. This review explores the immunomodulatory impact of gut-derived metabolites in IS, with a focus on short-chain fatty acids (SCFAs) and other bioactive substances. A comprehensive literature search was undertaken using MeSH terms such as gut microbiome, ischemic stroke, cerebral ischemia, brain infarction, intestinal flora, and gut-brain axis. We address how metabolites such as short-chain fatty acids produced by gut bacteria influence the host's immune system, which in turn affects the activity of neural networks linked to atherosclerosis, a major underlying mechanism of IS. Furthermore, this review also looks at new research opportunities and highlights evidence from studies conducted on humans and animals.